Ialugen Plus Akut
Ialugen Plus Akut is a medicine authorised by Swissmedic under authorisation number 68027. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Biotechnological medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 02 September 2021 and the authorisation is valid without a time limit. ATC code D06BA51 places the medicine in the group Antibiotics and chemotherapeutics for dermatological use.
| Authorisation number | 68027 |
|---|---|
| Name | Ialugen Plus Akut |
| Full name | Ialugen Plus Akut, Creme |
| Authorisation holder | IBSA Institut Biochimique SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | D06BA51 |
| First authorisation | 02 September 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ialugen Plus Akut, Creme | D | 02 September 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | g | D06BA51 | 10.06.0. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ialugen Plus Akut authorised in Switzerland?
Yes. Ialugen Plus Akut is authorised by Swissmedic under authorisation number 68027, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ialugen Plus Akut have?
Ialugen Plus Akut is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Ialugen Plus Akut?
The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.